Get started
CANSINO BIOLOGICS INC.CANSINO BIOLOGICS INC.CANSINO BIOLOGICS INC.

CANSINO BIOLOGICS INC.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

688185 chart


Full chart

688185 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.15 B‬ CNY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.91 CNY
Net income (FY)
‪−1.48 B‬ CNY
Revenue (FY)
‪349.12 M‬ CNY
Shares float
‪67.03 M‬
Beta (1Y)
1.52

Employees


Employees (FY)
‪1.49 K‬
Change (1Y)
−797 −34.79%
Revenue / Employee (1Y)
‪32.91 K‬ CNY
Net income / Employee (1Y)
‪−139.79 K‬ CNY

About CANSINO BIOLOGICS INC.


Sector
Health Technology
Industry
Biotechnology
CEO
Xue Feng Yu
Website
cansinotech.com
Headquarters
Tianjin
Founded
2009
ISIN
CNE100004BM0
FIGI
BBG00RPFF324
CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

688185 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 688185 is 57.50 CNY — it has increased by 2.32% in the past 24 hours. Watch CANSINO BIOLOGICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CANSINO BIOLOGICS INC. stocks are traded under the ticker 688185.
688185 stock has fallen by −2.03% compared to the previous week, the month change is a 15.32% rise, over the last year CANSINO BIOLOGICS INC. has showed a −28.71% decrease.
We've gathered analysts' opinions on CANSINO BIOLOGICS INC. future price: according to them, 688185 price has a max estimate of 68.68 CNY and a min estimate of 20.54 CNY. Watch 688185 chart and read a more detailed CANSINO BIOLOGICS INC. stock forecast: see what analysts think of CANSINO BIOLOGICS INC. and suggest that you do with its stocks.
688185 reached its all-time high on Jun 23, 2021 with the price of 798.00 CNY, and its all-time low was 37.12 CNY and was reached on Aug 23, 2024. View more price dynamics on 688185 chart.
See other stocks reaching their highest and lowest prices.
688185 stock is 4.50% volatile and has beta coefficient of 1.52. Track CANSINO BIOLOGICS INC. stock price on the chart and check out the list of the most volatile stocks — is CANSINO BIOLOGICS INC. there?
Today CANSINO BIOLOGICS INC. has the market capitalization of ‪13.82 B‬, it has increased by 10.65% over the last week.
Yes, you can track CANSINO BIOLOGICS INC. financials in yearly and quarterly reports right on TradingView.
CANSINO BIOLOGICS INC. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
688185 earnings for the last quarter are 0.01 CNY per share, whereas the estimation was −0.35 CNY resulting in a 102.89% surprise. The estimated earnings for the next quarter are −0.19 CNY per share. See more details about CANSINO BIOLOGICS INC. earnings.
CANSINO BIOLOGICS INC. revenue for the last quarter amounts to ‪263.65 M‬ CNY, despite the estimated figure of ‪216.12 M‬ CNY. In the next quarter, revenue is expected to reach ‪362.39 M‬ CNY.
688185 net income for the last quarter is ‪2.96 M‬ CNY, while the quarter before that showed ‪−55.28 M‬ CNY of net income which accounts for 105.36% change. Track more CANSINO BIOLOGICS INC. financial stats to get the full picture.
As of Nov 5, 2024, the company has ‪1.49 K‬ employees. See our rating of the largest employees — is CANSINO BIOLOGICS INC. on this list?
Like other stocks, 688185 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANSINO BIOLOGICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CANSINO BIOLOGICS INC. technincal analysis shows the strong buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CANSINO BIOLOGICS INC. stock shows the neutral signal. See more of CANSINO BIOLOGICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.